LifeVantage Corporation (LFVN) — Form 10-Q Summary
Reporting period: Fiscal first quarter ended September 30, 2021; comparisons are with the three months ended September 30, 2020 unless noted. Unaudited. Dollar amounts are in millions except per-share data.
Business context
LifeVantage sells dietary supplements, personal-care products and related wellness products through a commission-based direct-selling network in the Americas and Asia/Pacific & Europe. Business performance depends substantially on attracting and retaining independent distributors and customers.
Key financial results
| Metric | Q1 FY2022 | Q1 FY2021 | Change |
|---|---|---|---|
| Revenue | $53.2 | $54.8 | Down 2.9% |
| Gross profit / margin | $43.8 / 82.3% | $45.4 / 82.9% | Margin down 0.6 percentage points |
| Operating income / margin | $4.6 / 8.7% | $3.5 / 6.4% | Income up 31.9% |
| Net income | $3.3 | $2.5 | Up 35.3% |
| Diluted EPS | $0.25 | $0.17 | Up $0.08 |
| Operating cash flow | $0.5 | $(1.1) | Improved by $1.5 |
| Capital expenditures | $0.4 | $1.0 | — |
Gross margin declined primarily due to higher inventory-obsolescence and customer-shipping costs and changes in geographic and product mix. Commissions and incentives were $24.1 million (45.3% of revenue), versus $25.6 million (46.8%). SG&A was $15.1 million (28.3% of revenue), versus $16.3 million (29.7%). The lower SG&A reflected reduced severance, legal and office-related costs, partly offset by higher event and travel spending.
Balance sheet, liquidity and capital
- Cash was $19.9 million at September 30, down from $23.2 million at June 30, 2021. Working capital was $22.6 million, compared with $22.9 million.
- Total assets were $75.6 million and total liabilities were $38.3 million. Current assets were $44.9 million versus current liabilities of $22.3 million.
- The balance sheet reports no outstanding term-loan balance. The credit facility includes a revolving facility of up to $5.0 million; the filing does not clearly state the amount, if any, drawn at quarter-end. The facility matures March 31, 2024, with an interest-rate floor of 4.00%. The company reported compliance with its covenants.
- Operating lease liabilities totaled $17.8 million; contractual lease obligations were $20.7 million before discounting. Other operating commitments, primarily marketing and inventory purchases, were $14.8 million.
- Repurchased approximately 460,000 shares for $3.5 million during the quarter; $8.0 million remained under the $35 million authorization. Cash used in financing activities was $3.3 million.
Management said cash and expected operating cash flow should meet requirements for at least the next 12 months. It also cited the possibility of raising capital or reducing spending if needed, noting that credit-facility covenants constrain some financing and repurchase activity.
Material changes and management commentary
- Revenue fell 5.8% in the Americas to $36.4 million, alongside a 9.4% decline in regional active accounts. Asia/Pacific & Europe revenue rose 3.9% to $16.8 million, with regional active accounts up 8.9%.
- Japan revenue declined 5.6% as reported, but 1.1% on a constant-currency basis. Australia and New Zealand revenue increased 41.7%; Greater China increased 24.1%.
- Worldwide active accounts declined 4.7% to 164,000: active distributors fell 8.8% to 62,000 and active customers fell 1.9% to 102,000. Americas account declines were partly offset by growth in Asia/Pacific & Europe.
- Management cited ongoing COVID-19 effects on in-person recruiting, events and distribution, while describing plans for hybrid meetings and continued product and market expansion. The company launched LifeVantage IC Bright at its October 2021 convention and expected product expansion to support growth; no quantified revenue or earnings guidance was provided.
- The company expects SG&A as a percentage of revenue to remain steady for the remainder of fiscal 2022. It expects the effective tax rate to fluctuate slightly, with the rate subject to discrete items and other uncertainties.
Risks, contingencies and unusual items
- COVID-19, distributor recruitment and retention, supply-chain and transportation disruptions, product acceptance, foreign exchange, and regulatory compliance remain business risks. About 36% of quarterly revenue was generated outside the United States; management estimated a 10% strengthening of the U.S. dollar against relevant currencies would have reduced quarterly revenue by $1.7 million.
- A class action, Smith v. LifeVantage Corp., continues on a securities claim under Section 12(2). Plaintiffs’ class-certification motion was pending; the company had not accrued a loss, stating liability was not probable or estimable, and intends to defend the case. An unfavorable outcome could materially affect results or financial condition.
- The company reported no other probable loss contingencies requiring accrual or disclosure and no off-balance-sheet arrangements. Its $2.2 million investment in Gig Economy Group is an early-stage, illiquid equity investment that could be impaired.
- Inventory-obsolescence expense was approximately $0.3 million, compared with $0.1 million a year earlier. No derivative instruments were held at quarter-end.
Investor verification points
- Track whether distributor and customer account declines, particularly in the Americas, stabilize and translate into revenue trends.
- Assess whether growth in Asia/Pacific & Europe and new product launches can offset lower Americas and Japan sales, including currency effects.
- Monitor operating cash conversion, inventory obsolescence, cash levels and share repurchases, as the quarter’s positive operating cash flow was modest relative to net income.
- Review revolving-credit usage, covenant compliance and liquidity as lease and other contractual obligations come due.
- Follow the class-certification ruling and any change in the company’s assessment of potential litigation losses.